Compounds useful for treating neurodegenerative disorders

Details for Australian Patent Application No. 2006247244 (hide)

Owner Satori Pharmaceuticals, Inc.

Inventors Schroeder, Frank; Pal, Kollol; Findeis, Mark A.

Agent Davies Collison Cave

Pub. Number AU-B-2006247244

PCT Pub. Number WO2006/124956

Priority 60/681,662 17.05.05 US

Filing date 16 May 2006

Wipo publication date 23 November 2006

Acceptance publication date 17 May 2012

International Classifications

C07J 53/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

C07J 71/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/124956 Priority application(s): WO2006/124956

17 May 2012 Application Accepted

  Published as AU-B-2006247244

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006247249-Method of treating Lymphangioleiomyomatosis (LAM)

2006247243-Pressure activated trap primer and water hammer combination